Neuroprotective Efficacy of Methylene Blue in Ischemic Stroke: An MRI Study

Methylene blue (MB) has unique energy-enhancing and antioxidant properties and is FDA-approved drug to treat methemoglobinemia and cyanide poisoning. This study evaluated the efficacy of MB to treat ischemic stroke in rats using longitudinal MRI and behavioral measures. Rats were subjected to 60-min...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Qiang, Du, Fang, Huang, Shiliang, Rodriguez, Pavel, Watts, Lora Talley, Duong, Timothy Q.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836814/
https://www.ncbi.nlm.nih.gov/pubmed/24278191
http://dx.doi.org/10.1371/journal.pone.0079833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836814/
https://www.ncbi.nlm.nih.gov/pubmed/24278191
http://dx.doi.org/10.1371/journal.pone.0079833

Ejemplares similares